This service provides comprehensive absorption, distribution, metabolism, and excretion (ADME) studies to support the non-clinical development of healthcare products, including advanced therapies and chemical-based innovations. It encompasses both in vitro and in vivo ADME assessments, pharmacokinetic profiling, and toxicokinetic evaluations, alongside tailored advisory support to define an appropriate development roadmap aligned with the product profile and regulatory requirements. The service is designed for EIC beneficiaries, including public research organisations (universities and research institutes) and private sector entities (biotechnology and pharmaceutical companies) developing health-related products such as ATMPs or chemicals. Its primary objective is to characterise the ADME profile of a substance, providing a detailed understanding of its physiological pathway, biotransformation, and elimination within the organism. The duration of the service depends on the study design, expected residence time of the compound, and analytical methods employed, typically ranging from a few weeks to several months. The engagement begins with a protocol development phase, during which the study design is defined in close collaboration with the beneficiary. This is followed by study execution, data analysis, and the preparation of a comprehensive final report. For GLP studies, all phases, including protocolisation, execution, analysis, and reporting, are conducted under strict quality control and audited in compliance with GLP requirements. All studies are performed under ISO 9001:2015-certified quality management systems, with GLP compliance applied where required. The service is delivered by in-house scientific teams, supported by internal auditors and regulatory experts to ensure high-quality outputs and adherence to international standards. As a result, beneficiaries receive a robust and comprehensive final study report suitable for internal decision-making and/or regulatory use, enabling informed progression of their product development pipeline.
Services are provided on a fee-for-service basis. Quotes are prepared case by case according to study design, animal species/model selected, analytical complexity, sampling schedule, workload, consumables and equipment requirements. A tailored proposal is issued after technical discussion of the project and intended use of the data. The hourly rate ranges from €100 to €265 and excludes materials, animals and housing costs (where applicable), and equipment.
Final timelines depend on the study design, analytical workflow, sample collection plan, and analytics, ranging from one week to up to 4-5 months.
Access to Infrastructure & R&D Support
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.